Understanding Bone Stem Cells in Osteogenesis Imperfecta and Craniofacial Repair
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues
This research explores how special bone stem cells work in the face and skull, especially for people with bone conditions like Osteogenesis Imperfecta, to help bones heal and stay strong.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11161496 on NIH RePORTER |
What this research studies
Our bones rely on special cells called skeletal stem cells to repair themselves and stay healthy, particularly in the face and skull. We are learning more about these specific stem cells and how they are controlled, as their function is often disrupted in conditions like Osteogenesis Imperfecta. This project aims to discover the unique features of these craniofacial stem cells and see if boosting a signal called Wnt1, possibly with an antibody treatment, can improve bone healing after injury. By understanding these processes, we hope to find new ways to help bones regenerate and repair themselves.
Who could benefit from this research
Good fit: This foundational research is relevant to patients experiencing bone injuries, particularly in the craniofacial area, and those with genetic bone disorders such as Osteogenesis Imperfecta.
Not a fit: Patients without bone injuries or conditions affecting skeletal stem cell function are unlikely to directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve bone healing and strength for individuals with bone injuries or conditions like Osteogenesis Imperfecta.
How similar studies have performed: While the specific markers and mechanisms being explored are novel, preliminary data supports altered craniofacial stem cell function in Osteogenesis Imperfecta, building on existing knowledge of Wnt signaling in bone.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Lee, Brendan — Baylor College of Medicine
- Study coordinator: Lee, Brendan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.